Home | All results_reference

[RDF data]
Results Reference #1131

Resource URI: http://static.linkedct.org/resource/results_reference/1131
linkedct:citation Maris J, Minturn J, Evans A, et al.: Phase I trial of the orally bioavailable TRK tyrosine kinase inhibitor CEP-701 in refractory neuroblastoma: a New Approaches to Neuroblastoma Therapy (NANT) study. [Abstract] Pediatr Blood Cancer 45 (4 Suppl 1): A-0.129, 416, 2005.
rdfs:label Results Reference #1131
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00084422>
linkedct:results_reference_id 1131 (xsd:int)
rdf:type linkedct:results_reference